Camp4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	99.21	109.52	64.04	38.38	83.19
Cash & Short-Term Investments	99.21	109.52	64.04	38.38	83.19
Cash Growth	101.14%	71.02%	66.86%	-53.86%	-
Other Current Assets	2.99	4.58	2.34	1.63	1.22
Total Current Assets	102.2	114.1	66.38	40.01	84.41
Net Property, Plant & Equipment	2.37	2.82	10.3	13.31	16.79
Other Long-Term Assets	0.89	0.89	1.62	1.62	1.35
Total Assets	105.46	117.81	78.31	54.95	102.55
Accounts Payable	0.86	0.18	1.21	1.04	2.15
Accrued Expenses	4.3	5.63	4.83	3.3	3.43
Short-Term Debt	-	-	-	0.41	-
Current Portion of Leases	0.38	0.29	2.99	3.06	2.37
Unearned Revenue	11.08	9.39	0.39	-	-
Other Current Liabilities	-	0.03	0.18	-	-
Total Current Liabilities	16.62	15.51	9.6	7.81	7.95
Long-Term Debt	-	-	-	0.09	-
Long-Term Leases	1.74	1.69	5.49	8.64	10.03
Other Long-Term Liabilities	56.19	52.9	0.07	0	0
Total Long-Term Liabilities	57.93	54.59	5.57	8.72	10.03
Total Liabilities	74.56	70.1	15.16	16.53	17.93
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	341.38	339.85	274.9	36.23	33.14
Retained Earnings	-310.49	-292.16	-211.75	-159.96	-110.67
Minority Interest	-	-	-	162.15	162.15
Shareholders' Equity	30.9	47.7	63.14	-123.73	-77.53
Total Liabilities & Equity	105.46	117.81	78.31	54.95	102.55
Total Debt	2.12	1.97	8.49	12.18	12.4
Net Cash (Debt)	97.09	107.54	55.55	26.2	70.8
Net Cash Growth	-9.72%	93.59%	112.05%	-63.00%	-
Net Cash Per Share	2.44	3.54	11.85	66.33	198.44
Book Value	30.9	47.7	63.14	-123.73	-77.53
Book Value Per Share	0.78	1.57	13.46	-313.26	-217.32
Tangible Book Value	30.9	47.7	63.14	-123.73	-77.53
Tangible Book Value Per Share	0.78	1.57	13.46	-313.26	-217.32

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q